On August 7, the U.S. Food and Drug Administration (FDA) approved the nalmefene hydrochloride auto-injector that is used in the treatment of opioid overdose. The treatment is used to treat opioid ...

The New Drug Application for the Naloxone Auto-injector 10 mg was submitted on August 31, 2021, and was granted Fast Track Designation by the FDA. The product is specifically indicated for ...

As reported earlier this month, the US Food and Drug Administration (FDA) approved Purdue Pharma's abbreviated new drug application for a prefilled, single 1.5-mg dose of nalmefene auto-injector ...

HARTFORD, Conn. (WTNH) — Recently, the Federal Drug Administration announced the approval of nalmefene auto-injector for the emergency treatment of opioid overdose, another tool for combatting ...

Purdue President and CEO Dr. Craig Landau said that if the FDA approves the auto-injector, Purdue will “distribute this medication for no profit, as part of our commitment to help abate the ...

The Naloxone HCI Auto-injector from Pirouette Medical, based in Portsmouth, has won the title of the NH Tech Alliance’s 2024 Product of the Year. Five New Hampshire businesses competed in the ...

On August 7, the U.S. Food and Drug Administration (FDA) approved the nalmefene hydrochloride auto-injector that is used in the treatment of opioid overdose. The treatment is used to treat opioid ...